Skip to main content
Top
Published in: International Urogynecology Journal 4/2013

01-04-2013 | Original Article

Association of bladder pain syndrome/interstitial cystitis with urinary calculus: a nationwide population-based study

Authors: Joseph Keller, Yi-Kuang Chen, Herng-Ching Lin

Published in: International Urogynecology Journal | Issue 4/2013

Login to get access

Abstract

Introduction and hypothesis

Although one prior study reported an association between bladder pain syndrome/interstitial cystitis (BPS/IC) and urinary calculi (UC), no population-based study to date has been conducted to explore this relationship. Therefore, using a population-based data set in Taiwan, this study set out to investigate the association between BPS/IC and a prior diagnosis of UC.

Methods

This study included 9,269 cases who had received their first-time diagnosis of BPS/IC between 2006 and 2007 and 46,345 randomly selected controls. We used conditional logistic regression analysis to compute the odds ratio (OR) and its corresponding 95 % confidence interval (CI) for having been previously diagnosed with UC between cases and controls.

Results

There was a significant difference in the prevalence of prior UC between cases and controls (8.1 vs 4.3 %, p < 0.001). Conditional logistic regression analysis revealed that cases were more likely to have been previously diagnosed with UC than controls (OR = 1.70; 95 % CI = 1.56–1.84) after adjusting for chronic pelvic pain, irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, panic disorder, migraine, sicca syndrome, allergy, endometriosis, and asthma. BPS/IC was found to be significantly associated with prior UC regardless of stone location; the adjusted ORs of kidney calculus, ureter calculus, bladder calculus, and unspecified calculus when compared to controls were 1.58 (95 % CI = 1.38–1.81), 1.73 (95 % CI = 1.45–2.05), 3.80 (95 % CI = 2.18–6.62), and 1.83 (95 % CI = 1.59–2.11), respectively.

Conclusions

This work generates the hypothesis that UC may be associated with BPS/IC.
Literature
1.
go back to reference Long LO, Park S (2007) Update on nephrolithiasis management. Minerva Urol Nefrol 59:317–325PubMed Long LO, Park S (2007) Update on nephrolithiasis management. Minerva Urol Nefrol 59:317–325PubMed
2.
go back to reference Goldfarb DS (2003) Increasing prevalence of kidney stones in the United States. Kidney Int 63:1951–1952PubMedCrossRef Goldfarb DS (2003) Increasing prevalence of kidney stones in the United States. Kidney Int 63:1951–1952PubMedCrossRef
3.
go back to reference Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef
4.
go back to reference López M, Hoppe B (2010) History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol 25:49–59PubMedCrossRef López M, Hoppe B (2010) History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol 25:49–59PubMedCrossRef
5.
go back to reference Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69:34–40PubMedCrossRef Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69:34–40PubMedCrossRef
6.
go back to reference Chow WH, Lindblad P, Gridley G, Nyrén O, McLaughlin JK, Linet MS, Pennello GA, Adami HO, Fraumeni JF Jr (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89:1453–1457PubMedCrossRef Chow WH, Lindblad P, Gridley G, Nyrén O, McLaughlin JK, Linet MS, Pennello GA, Adami HO, Fraumeni JF Jr (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89:1453–1457PubMedCrossRef
7.
go back to reference Messing EM, Stamey TA (1978) Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 12:381–392PubMedCrossRef Messing EM, Stamey TA (1978) Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 12:381–392PubMedCrossRef
8.
go back to reference Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT (2007) Rational approaches to the treatment of patients with interstitial cystitis. Urology 69:73–81PubMedCrossRef Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT (2007) Rational approaches to the treatment of patients with interstitial cystitis. Urology 69:73–81PubMedCrossRef
9.
go back to reference Metts JF (2001) Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 64:1199–1206PubMed Metts JF (2001) Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 64:1199–1206PubMed
10.
go back to reference Driscoll A, Teichman JMH (2001) How do patients with interstitial cystitis present? J Urol 166:2118–2120PubMedCrossRef Driscoll A, Teichman JMH (2001) How do patients with interstitial cystitis present? J Urol 166:2118–2120PubMedCrossRef
11.
go back to reference Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26PubMedCrossRef Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26PubMedCrossRef
12.
go back to reference Rosenberg MT, Newman DK, Page SA (2007) Interstitial cystitis/painful bladder syndrome: symptom recognition is key to early identification, treatment. Cleve Clin J Med 74(Suppl 3):S54–S62PubMedCrossRef Rosenberg MT, Newman DK, Page SA (2007) Interstitial cystitis/painful bladder syndrome: symptom recognition is key to early identification, treatment. Cleve Clin J Med 74(Suppl 3):S54–S62PubMedCrossRef
13.
go back to reference Leppilahti M, Tammela TL, Huhtala H, Auvinen A (2002) Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol 168:139–143PubMedCrossRef Leppilahti M, Tammela TL, Huhtala H, Auvinen A (2002) Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol 168:139–143PubMedCrossRef
14.
go back to reference Rosenberg MT, Hazzard M (2005) Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol 174:2231–2234PubMedCrossRef Rosenberg MT, Hazzard M (2005) Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol 174:2231–2234PubMedCrossRef
15.
go back to reference Rosenberg MT, Page S, Hazzard MA (2007) Prevalence of interstitial cystitis in a primary care setting. Urology 69:48–52PubMedCrossRef Rosenberg MT, Page S, Hazzard MA (2007) Prevalence of interstitial cystitis in a primary care setting. Urology 69:48–52PubMedCrossRef
16.
go back to reference Langenberg PW, Wallach EE, Clauw DJ, Howard FM, Diggs CM, Wesselmann U, Greenberg P, Warren JW (2010) Pelvic pain and surgeries in women before interstitial cystitis/painful bladder syndrome. Am J Obstet Gynecol 202:286.e1–286.e6CrossRef Langenberg PW, Wallach EE, Clauw DJ, Howard FM, Diggs CM, Wesselmann U, Greenberg P, Warren JW (2010) Pelvic pain and surgeries in women before interstitial cystitis/painful bladder syndrome. Am J Obstet Gynecol 202:286.e1–286.e6CrossRef
17.
go back to reference van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53:60–67PubMedCrossRef van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53:60–67PubMedCrossRef
18.
go back to reference Tissot WD, Diokno AC, Peters KM (2004) A referral center’s experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 172:478–480PubMedCrossRef Tissot WD, Diokno AC, Peters KM (2004) A referral center’s experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 172:478–480PubMedCrossRef
19.
go back to reference Warren JW, Wesselmann U, Morozov V, Langenberg PW (2011) Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. Urology 77:313–319PubMedCrossRef Warren JW, Wesselmann U, Morozov V, Langenberg PW (2011) Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. Urology 77:313–319PubMedCrossRef
20.
go back to reference Warren JW, Howard FM, Cross RK, Good JL, Weissman MM, Wesselmann U, Langenberg P, Greenberg P, Clauw DJ (2009) Antecedent nonbladder syndromes in case–control study of interstitial cystitis/painful bladder syndrome. Urology 73:52–57PubMedCrossRef Warren JW, Howard FM, Cross RK, Good JL, Weissman MM, Wesselmann U, Langenberg P, Greenberg P, Clauw DJ (2009) Antecedent nonbladder syndromes in case–control study of interstitial cystitis/painful bladder syndrome. Urology 73:52–57PubMedCrossRef
21.
22.
go back to reference Lokeshwar VB, Selzer MG, Cerwinka WH, Gomez MF, Kester RR, Bejany DE, Gousse AE (2005) Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity. J Urol 174:344–349PubMedCrossRef Lokeshwar VB, Selzer MG, Cerwinka WH, Gomez MF, Kester RR, Bejany DE, Gousse AE (2005) Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity. J Urol 174:344–349PubMedCrossRef
23.
go back to reference Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM, Kushner L, Keay SK (2002) A comparison of multiple urine markers for interstitial cystitis. J Urol 167:2461–2469PubMedCrossRef Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM, Kushner L, Keay SK (2002) A comparison of multiple urine markers for interstitial cystitis. J Urol 167:2461–2469PubMedCrossRef
24.
go back to reference Parvin M, Shakhssalim N, Basiri A, Miladipour AH, Golestan B, Mohammadi Torbati P, Azadvari M, Eftekhari S (2011) The most important metabolic risk factors in recurrent urinary stone formers. Urol J 8:99–106PubMed Parvin M, Shakhssalim N, Basiri A, Miladipour AH, Golestan B, Mohammadi Torbati P, Azadvari M, Eftekhari S (2011) The most important metabolic risk factors in recurrent urinary stone formers. Urol J 8:99–106PubMed
25.
go back to reference Parsons CL (2007) The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69:9–16PubMedCrossRef Parsons CL (2007) The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69:9–16PubMedCrossRef
26.
go back to reference Ruggieri MR Sr (2006) Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction. Nat Clin Pract Urol 3:206–215PubMedCrossRef Ruggieri MR Sr (2006) Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction. Nat Clin Pract Urol 3:206–215PubMedCrossRef
27.
go back to reference Sun Y, Chai TC (2006) Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol 290:C27–C34PubMedCrossRef Sun Y, Chai TC (2006) Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol 290:C27–C34PubMedCrossRef
28.
go back to reference Erckson DR, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, Tomaszewski JE (2004) Is urine methylhistamine a useful marker for interstitial cystitis? J Urol 172:2256–2260PubMedCrossRef Erckson DR, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, Tomaszewski JE (2004) Is urine methylhistamine a useful marker for interstitial cystitis? J Urol 172:2256–2260PubMedCrossRef
30.
31.
go back to reference Ohshima H, Tatemichi M, Sawa T (2003) Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417:3–11PubMedCrossRef Ohshima H, Tatemichi M, Sawa T (2003) Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417:3–11PubMedCrossRef
32.
go back to reference Grover S, Srivastava A, Lee R, Tewari AK, Te AE (2011) Role of inflammation in bladder function and interstitial cystitis. Ther Adv Urol 3:19–33PubMedCrossRef Grover S, Srivastava A, Lee R, Tewari AK, Te AE (2011) Role of inflammation in bladder function and interstitial cystitis. Ther Adv Urol 3:19–33PubMedCrossRef
Metadata
Title
Association of bladder pain syndrome/interstitial cystitis with urinary calculus: a nationwide population-based study
Authors
Joseph Keller
Yi-Kuang Chen
Herng-Ching Lin
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue 4/2013
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-012-1917-6

Other articles of this Issue 4/2013

International Urogynecology Journal 4/2013 Go to the issue